Related Experiment Videos

C-reactive protein as an independent risk factor for carotid atherosclerosis in hemodialysis patients

Biserka Tirmenstajn-Janković1, Nada Dimković

  • 1Zdravstveni centar Zajecar, Odeljenje nefrologije i hemodijalize. tribally@ptt.yu

Medicinski Pregled
|March 11, 2006
PubMed

Insights

Inflammation, indicated by C-reactive protein (CRP), is linked to early atherosclerosis in hemodialysis patients. Elevated CRP levels correlate with increased markers of subclinical atherosclerosis, highlighting inflammation's role.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Biomarkers

Background:

  • C-reactive protein (CRP) is a known cardiovascular disease risk factor.
  • The link between CRP and early atherosclerosis, particularly in hemodialysis patients, requires further investigation.

Purpose of the Study:

  • To investigate the relationship between CRP levels and indicators of subclinical atherosclerosis.
  • To assess the role of inflammation in atherosclerosis development among hemodialysis patients.

Main Methods:

  • B-mode ultrasound imaging was used to measure common carotid artery intima-media thickness, lumen diameter, and cross-sectional intima-media area (CSIM area).
  • 43 hemodialysis (HD) patients and 21 healthy controls were included.
  • CRP levels were measured, with inflammation defined as CRP > 10 mg/l.

Main Results:

  • HD patients exhibited significantly higher CSIM area and lumen diameter compared to controls.
  • 58.1% of HD patients showed inflammation (CRP > 10 mg/l).
  • Inflammation was associated with higher ultrasonographic atherosclerosis markers and increased prevalence of atherosclerotic vascular diseases. Higher CSIM area correlated with elevated CRP, advanced age, and smoking.

Conclusions:

  • Inflammation plays a key role in the development of atherosclerosis in hemodialysis patients.
  • CRP is a valuable marker for assessing subclinical atherosclerosis in this population.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...